2021年10月7日简报:张文宏认为新冠结束时间已不远!口服药,加强针成为全球重新开放的保障;全球新增新冠确诊病例和死亡人数继续下降

2021-10-07 MedSci整理 MedSci整理

截至北京时间2021年10月7日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过23701万例,新增413,161例,达到237,010,37

截至北京时间2021年10月7日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎COVID-19)病例超过23701万例,新增413,161例,达到237,010,377例。累计死亡病例483.8万例,达到4,838,661例。新增死亡为7,430例。康复为214,134,911例,重症和危重症病人达到85,073例;全球新冠确诊病例超过100万例的国家达35个,110个国家病例超10万例。昨日报道:2021年10月6日简报:美国民众反智,奇葩新冠阴谋论流行,大批民众拒绝接种疫苗;欧洲药品管理局可能开始加速评估默克的新冠口服药;新西兰宣布放弃“彻底消除新冠”战略

世卫组织、张文宏:新冠结束时间已不远!2022年初将全球解放?

据海外网报道,联合国下属世界卫生组织近日给出新冠疫情结束时间:“新冠大流行将于2022年年初结束。”

据俄罗斯卫星通讯社24日报道,世界卫生组织欧洲区域办事处主任汉斯•克鲁格23日表示,新冠大流行将于2022年年初结束。

张文宏最后写道:对于未来,大家一定要相信,我国和世界的科技正在迅速发展,彻底免除病毒困扰只是时间问题,而且可能不会太过长久。

张伯礼:年底有望恢复到疫情前状态

近日,中国工程院院士张伯礼接受健康时报记者采访时表示,“现在国内已经连续多天没有新增本土病例,疫情防控整体形势比较乐观。特别是到了三月份春暖花开,疫情会进一步平缓。”

“综合分析,今年整体的疫情防控形势都会平稳趋好,目前国际疫情稳步趋缓,国内已经实现了常态。”

张伯礼院士进一步表示,所谓拐点就是国内没有连续新增本土病例、没有高中风险地区,常态化防控疫情,有序地复工复学,逐步恢复到正常的生活。

也有人表示,虽然现在疫情已经控制住,但还是心有余悸,很是怀念疫情之前的那种生活。张伯礼院士表示,“这一天不会太远,估计年底疫情会更加常态化,能很大程度地恢复到疫情之前的水平。”

尽管拐点即将到来,但防控也不能松懈。张伯礼院士提醒,抗疫期间形成的良好的制度和习惯不要丢掉。少聚集、保持社交距离、勤洗手、勤通风这些好习惯应该长期坚持。下一步的防控任务是常态防空和精准防空相结合。外防输入,包括人传人和物传人仍然是重点,应该继续加大海关检疫、归国人员隔离等措施。

挪威宣布全面开放,不再强制接种疫苗

在最新一次发布会上,挪威首相表示将新冠降级为“一般流感”,也就是相当于季节性呼吸道疾病的等级,因此全国就没有必要再实施如此严格的防疫措施。在讲话之后官方就进行了公布,表示各地区限制措施将会在25日下午16:00时正式结束,除了公共场所恢复开放外,位于挪威繁华地区的夜店也可正常开放,对于佩戴口罩基本上没有规定。

在近段时间,世界上多个国家都宣布取消之前采取的大部分或者所有防疫措施,让国家回归到正常状态当中,挪威也宣布了同样的决定。该国首相表态称,挪威在之前采取了前所未有的防疫措施,目前这一措施的实施已经有561天的时间,现在是国家回到正常的轨道中的时候了。

公共卫生相关部门的官员也补充说明,称挪威如今已经将新冠肺炎归类为一般疾病,意味着其对国内民众的身体健康不会造成特别重大的影响,尤其是国内大部分人已经得到了充分的保障的前提下,新冠肺炎完全可以被认为是季节性呼吸道疾病当中的一种。在这一决定下达之后,挪威的正常经济活动将被允许重回正常状态,所有的公共场所可以重新投入运营,包括夜店、酒吧这类人群密集的场所,也可以重启。

挪威目前唯一相对来说比较严格的措施就是,针对入境人员,对于一些从高风险国家进入的人员,挪威政府会要求这些入境人员遵守相应的防疫措施,至于其他危险性并不高的国家民众,在入境时需要遵守的防疫规定会相对宽松很多。

日本新冠疫苗全程接种率超越美国,越年轻的群体接种率越低

共同社10月5日报道,日本政府4日发布统计结果称,完成两剂新冠疫苗接种的人口达到60.9%,至少接种一剂的比例为71.3%。两剂接种比例已超过率先接种的美国,一剂比例也超越德国,与英国基本持平。不过10至30多岁人群完成两剂接种的人不到50%,向年轻人普及疫苗成为课题。

据报道,前官房长官加藤胜信在4日的记者会上表示:“集结内阁之力采取措施,得以迅速推进了作为王牌的疫苗接种。”完成两剂接种的比例从各年龄段来看,65岁以上达到89.4%,与之相对,12至19岁只有26.8%、20至29岁为39.4%、30至39岁为42.8%,越是年轻人群接种率越低。

报道称,日本政府力争在10到11月较早时候完成所有希望接种国民的疫苗接种。政府的新冠对策小组会推测称,最有可能出现的情况是60岁以上人群85%、40至59岁人群70%、20至39岁人群60%的接种率,而现状是越是年轻人群离上述比例越远。

日本盐野义的口服治疗新冠药物可能比默沙东的效果可能更好

在未来2个月内盐野义制药会正式向日本政府提出上市许可申请。预计今年年底可以开始供应。年末将完成100万人份的生产。

这种药从最初的动物试验等结果显示,治疗效果比美国辉瑞公司等公司研发的同等药物更为效果显著。

也就是说,若是顺利上市,有了这种药,对于初期和轻症患者来说,比治疗感冒还要容易。

此次开发的口服药适用于轻度或无症状的新型患者,每日1次,连服5天。该药于今年7月开始了首期临床试验,从上月27日开始,以约2000人为对象,同时进行二期和三期的临床试验,目前还没有发现安全性方面的重大问题。

日本著名新冠病毒专家、国际医疗福祉大学主任教授松本哲哉指出,盐野义制药公司口服药的上市,患者可以在家自己服用,也可以大大减轻医疗的压力,可以预防重症化,也可以预防密切接触者感染病毒。

世卫组织:全球新增新冠确诊病例和死亡人数继续下降

联合国新闻10月6日消息,根据世界卫生组织的数据,全球新冠确诊病例和死亡人数继续下降,上周报告310万新增确诊病例和54000多例新增死亡病例。

世卫组织在其每周一次的流行病学更新发布会上表示,与前一周相比,新病例减少9%,而死亡人数大体稳定。 这延续了自8月以来观察到的趋势。在9月27日至10月3日这一周,除欧洲与前一周保持稳定外,所有地区的新增病例数均有所下降。

每周新增病例减少最多的是非洲(43%),其次是东地中海(21%)、东南亚(19%)、美洲(12%)和西太平洋(12%)。

美国2021年新冠死亡病例数已超2020年总和

据美国广播公司当地时间10月6日报道,美国约翰斯·霍普金斯大学最新数据显示,2021年美国累计新冠肺炎死亡病例总数已经超过了该国2020年的新冠肺炎死亡病例数总和。

数据显示,自2021年1月1日以来,全美已有超过35.3万例新冠肺炎死亡病例,而2020年的新冠肺炎死亡病例总数为35.2万例。此外,仅仅在过去一个月内,美国报告的新冠肺炎死亡病例数就超过4.7万例。

法国高等卫生署发布通知,建议为该国医务工作者接种第三剂新冠疫苗

据悉,这涉及约350万人,其中包括卫生机构的专业医护人员、社会机构的护理人员,以及运送病人及医疗物品的专业司机等。

此前,新冠疫苗加强针(第三剂)仅限为法国65岁以上以及患有疾病的“高风险”人群接种。

辉瑞新冠疫苗接种5个月后 预防感染有效率降至47%

英国《柳叶刀》发表的一项最新研究显示,接种两剂辉瑞疫苗5个月后,预防感染新冠病毒的有效率降至47%,但在预防与新冠感染相关的入院治疗方面,有效率仍保持在约90%。

研究人员认为,该疫苗有效性下降主要是由时间推移导致,而并非由于遇到了传播性更强的变异病毒。不过,研究人员也指出,这项研究存在一定局限性,如没有将接种者是否严格遵循“口罩令”、是否注意保持社交距离等因素纳入考量,而这些因素可能会对研究结果产生一定影响。

泛美卫生组织:新冠疫情已对全球 GDP 造成 4 万亿美元的损失

据泛美卫生组织,迄今为止,新冠疫情已对全球 GDP 造成 4 万亿美元的损失。 上个月整个美洲的新增新冠肺炎感染病例数量有所下降,美国和加拿大的新增病例有所下降,但墨西哥的新增病例却在增加。

瑞典暂停对 1991 年及以后出生的人群接种莫德纳新冠疫苗

当地时间 10 月 6 日,瑞典电视台报道,瑞典公共卫生局官网发文表示,已决定暂停对 1991 年及以后出生的人群接种莫德纳新冠疫苗。原因是接种疫苗导致副作用的风险增加,例如心肌炎或心包炎。数据表明,莫德纳疫苗与相关症状的关联明显,特别是在接种第二剂之后。该决定有效期至 2021 年 12 月 1 日。

丹麦将不会为 18 岁以下的青少年接种莫德纳新冠疫苗

当地时间 10 月 6 日,丹麦广播电视台报道,丹麦国家卫生委员会称,丹麦将不会为 18 岁以下的青少年接种莫德纳新冠疫苗。这是因为怀疑此类人群接种莫德纳新冠疫苗后,有心肌炎或心包炎发作的风险。丹麦国家卫生委员会还强调,心肌炎是一种极为罕见的副作用,通常病程较轻并会自行消失。

巴西将解除对英国、南非和印度等国的航空限制

巴西政府当地时间 10 月 6 日发布公告称,由于新冠疫情缓解,从即日起将不再限制来自英国、南非和印度的旅客入境巴西。巴西政府规定,来自这些国家的旅客在登机前依然需要向航空公司提交 24 小时内新冠病毒抗原测试和 72 小时内新冠病毒核酸检测阴性证明;在巴西转机旅客需在机场指定区域活动,离开指定区域或超过 24 小时抗原测试和 72 小时核酸检测期限者,须重新进行检测。航班乘务人员不在此规定范围内。

加拿大政府要求所有公职人员10月底前必须接种新冠疫苗

当地时间10月6日,加拿大总理特鲁多宣布,联邦政府将要求所有公职人员必须在10月月底前接种新冠疫苗,未完成接种者将被解职。

联邦公职人员既包括联邦政府的工作人员,也包括联邦警察以及全国性的交通部门,如飞机、火车和船舶等行业的雇员。

此外,为联邦部门提供服务的承包商所雇用的人员,如清洁工、在安检区内的商店和餐馆工作的人员等,也必须完成疫苗接种。承包商必须在10月29日前提交所有此类雇员接种疫苗的信息。据了解,此类雇员总数约为26.7万人。

上述人员如果在截止日期两周后仍未接种疫苗,将会受到纪律处分或失去工作。

全球疫苗接种情况

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2060871, encodeId=96f320608e1f3, content=<a href='/topic/show?id=49f63823396' target=_blank style='color:#2F92EE;'>#口服药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38233, encryptionId=49f63823396, topicName=口服药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Mon Jun 13 00:27:48 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967555, encodeId=c505196e5555f, content=<a href='/topic/show?id=7fe36335360' target=_blank style='color:#2F92EE;'>#死亡人数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63353, encryptionId=7fe36335360, topicName=死亡人数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Thu Jul 14 12:27:48 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058327, encodeId=5a8e105832ea1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:20:18 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058276, encodeId=650810582e6e9, content=短信的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Thu Oct 07 10:31:53 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058243, encodeId=a0a4105824308, content=期待<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc295543122, createdName=ms3000000340852430, createdTime=Thu Oct 07 08:00:42 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058242, encodeId=1ae510582426c, content=期待早日恢复正常, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Thu Oct 07 07:53:04 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058239, encodeId=2cfa105823957, content=新冠疫情防控成果初见。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Oct 07 07:48:21 CST 2021, time=2021-10-07, status=1, ipAttribution=)]
    2022-06-13 gdsun
  2. [GetPortalCommentsPageByObjectIdResponse(id=2060871, encodeId=96f320608e1f3, content=<a href='/topic/show?id=49f63823396' target=_blank style='color:#2F92EE;'>#口服药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38233, encryptionId=49f63823396, topicName=口服药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Mon Jun 13 00:27:48 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967555, encodeId=c505196e5555f, content=<a href='/topic/show?id=7fe36335360' target=_blank style='color:#2F92EE;'>#死亡人数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63353, encryptionId=7fe36335360, topicName=死亡人数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Thu Jul 14 12:27:48 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058327, encodeId=5a8e105832ea1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:20:18 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058276, encodeId=650810582e6e9, content=短信的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Thu Oct 07 10:31:53 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058243, encodeId=a0a4105824308, content=期待<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc295543122, createdName=ms3000000340852430, createdTime=Thu Oct 07 08:00:42 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058242, encodeId=1ae510582426c, content=期待早日恢复正常, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Thu Oct 07 07:53:04 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058239, encodeId=2cfa105823957, content=新冠疫情防控成果初见。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Oct 07 07:48:21 CST 2021, time=2021-10-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2060871, encodeId=96f320608e1f3, content=<a href='/topic/show?id=49f63823396' target=_blank style='color:#2F92EE;'>#口服药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38233, encryptionId=49f63823396, topicName=口服药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Mon Jun 13 00:27:48 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967555, encodeId=c505196e5555f, content=<a href='/topic/show?id=7fe36335360' target=_blank style='color:#2F92EE;'>#死亡人数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63353, encryptionId=7fe36335360, topicName=死亡人数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Thu Jul 14 12:27:48 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058327, encodeId=5a8e105832ea1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:20:18 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058276, encodeId=650810582e6e9, content=短信的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Thu Oct 07 10:31:53 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058243, encodeId=a0a4105824308, content=期待<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc295543122, createdName=ms3000000340852430, createdTime=Thu Oct 07 08:00:42 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058242, encodeId=1ae510582426c, content=期待早日恢复正常, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Thu Oct 07 07:53:04 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058239, encodeId=2cfa105823957, content=新冠疫情防控成果初见。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Oct 07 07:48:21 CST 2021, time=2021-10-07, status=1, ipAttribution=)]
    2021-10-07 老龙一点

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2060871, encodeId=96f320608e1f3, content=<a href='/topic/show?id=49f63823396' target=_blank style='color:#2F92EE;'>#口服药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38233, encryptionId=49f63823396, topicName=口服药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Mon Jun 13 00:27:48 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967555, encodeId=c505196e5555f, content=<a href='/topic/show?id=7fe36335360' target=_blank style='color:#2F92EE;'>#死亡人数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63353, encryptionId=7fe36335360, topicName=死亡人数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Thu Jul 14 12:27:48 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058327, encodeId=5a8e105832ea1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:20:18 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058276, encodeId=650810582e6e9, content=短信的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Thu Oct 07 10:31:53 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058243, encodeId=a0a4105824308, content=期待<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc295543122, createdName=ms3000000340852430, createdTime=Thu Oct 07 08:00:42 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058242, encodeId=1ae510582426c, content=期待早日恢复正常, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Thu Oct 07 07:53:04 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058239, encodeId=2cfa105823957, content=新冠疫情防控成果初见。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Oct 07 07:48:21 CST 2021, time=2021-10-07, status=1, ipAttribution=)]
    2021-10-07 查查佳佳

    短信的吗

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2060871, encodeId=96f320608e1f3, content=<a href='/topic/show?id=49f63823396' target=_blank style='color:#2F92EE;'>#口服药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38233, encryptionId=49f63823396, topicName=口服药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Mon Jun 13 00:27:48 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967555, encodeId=c505196e5555f, content=<a href='/topic/show?id=7fe36335360' target=_blank style='color:#2F92EE;'>#死亡人数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63353, encryptionId=7fe36335360, topicName=死亡人数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Thu Jul 14 12:27:48 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058327, encodeId=5a8e105832ea1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:20:18 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058276, encodeId=650810582e6e9, content=短信的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Thu Oct 07 10:31:53 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058243, encodeId=a0a4105824308, content=期待<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc295543122, createdName=ms3000000340852430, createdTime=Thu Oct 07 08:00:42 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058242, encodeId=1ae510582426c, content=期待早日恢复正常, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Thu Oct 07 07:53:04 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058239, encodeId=2cfa105823957, content=新冠疫情防控成果初见。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Oct 07 07:48:21 CST 2021, time=2021-10-07, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2060871, encodeId=96f320608e1f3, content=<a href='/topic/show?id=49f63823396' target=_blank style='color:#2F92EE;'>#口服药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38233, encryptionId=49f63823396, topicName=口服药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Mon Jun 13 00:27:48 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967555, encodeId=c505196e5555f, content=<a href='/topic/show?id=7fe36335360' target=_blank style='color:#2F92EE;'>#死亡人数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63353, encryptionId=7fe36335360, topicName=死亡人数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Thu Jul 14 12:27:48 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058327, encodeId=5a8e105832ea1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:20:18 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058276, encodeId=650810582e6e9, content=短信的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Thu Oct 07 10:31:53 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058243, encodeId=a0a4105824308, content=期待<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc295543122, createdName=ms3000000340852430, createdTime=Thu Oct 07 08:00:42 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058242, encodeId=1ae510582426c, content=期待早日恢复正常, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Thu Oct 07 07:53:04 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058239, encodeId=2cfa105823957, content=新冠疫情防控成果初见。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Oct 07 07:48:21 CST 2021, time=2021-10-07, status=1, ipAttribution=)]
    2021-10-07 学医无涯

    期待早日恢复正常

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2060871, encodeId=96f320608e1f3, content=<a href='/topic/show?id=49f63823396' target=_blank style='color:#2F92EE;'>#口服药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38233, encryptionId=49f63823396, topicName=口服药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Mon Jun 13 00:27:48 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967555, encodeId=c505196e5555f, content=<a href='/topic/show?id=7fe36335360' target=_blank style='color:#2F92EE;'>#死亡人数#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63353, encryptionId=7fe36335360, topicName=死亡人数)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Thu Jul 14 12:27:48 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058327, encodeId=5a8e105832ea1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:20:18 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058276, encodeId=650810582e6e9, content=短信的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Thu Oct 07 10:31:53 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058243, encodeId=a0a4105824308, content=期待<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc295543122, createdName=ms3000000340852430, createdTime=Thu Oct 07 08:00:42 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058242, encodeId=1ae510582426c, content=期待早日恢复正常, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Thu Oct 07 07:53:04 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058239, encodeId=2cfa105823957, content=新冠疫情防控成果初见。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Thu Oct 07 07:48:21 CST 2021, time=2021-10-07, status=1, ipAttribution=)]
    2021-10-07 yangchou

    新冠疫情防控成果初见。

    0

相关资讯

2021年9月28日简报:全国新冠疫苗接种剂次超22亿,新加坡单日新增新冠病例创纪录,“与新冠共处”后被迫收紧防疫措施,拜登接种加强针,美国务院发言人新冠检测结果呈阳性

截至北京时间2021年9月28日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过23296万例,新增314,779例,达到232,967,11

2021年10月5日简报:欧洲药管局批准所有成人打辉瑞加强针;卡塔尔将中国新冠疫苗列入认可疫苗清单;英国进一步简化入境政策

截至北京时间2021年10月5日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过23606万例,新增307,395例,达到236,062,47

2021年10月6日简报:美国民众反智,奇葩新冠阴谋论流行,大批民众拒绝接种疫苗;欧洲药品管理局可能开始加速评估默克的新冠口服药;新西兰宣布放弃“彻底消除新冠”战略

截至北京时间2021年10月6日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过23655万例,新增394,248例,达到236,554,40

Lancet:新冠疫苗BNT162b2预防德尔塔变体感染的有效率高达93%!

BNT162b2 疫苗在完全接种后 6 个月内具有很高的预防新冠肺炎住院的有效率,即使面对 δ 变体的广泛传播

2021年9月30日简报:天津全面开始接种加强针,儿童接种新冠疫苗正在争议,吸烟者感染新冠概率比普通人高80%,全球康复超过2.1亿人

截至北京时间2021年9月30日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过23395万例,新增428,517例,达到233,956,61

2021年10月2日简报:国内仅哈尔滨有新增病例,厦门连续2日零新增;阿根廷批准对3岁至11岁儿童接种中国国药新冠疫苗

截至北京时间2021年10月2日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过23500万例,新增444,374例,达到235,005,38